Semaglutide 2.4&#x2009;mg Cardiometabolic Long-Term Effects in Patients With Obesity or Overweight in a Real-World Setting: A Retrospective Cohort Study in the United States (SMILE)

Myocardial Infarction

Progression to type 2 diabetes among post-myocardial infarction patients with overweight or obesity: a real-world cohort study

Cardiovasc Diabetol

Tonnesen PT, Olesen KKW, Gyldenkerne C, Hansen MK, Stødkilde-Jørgensen N, Thrane PG, Andersen MH, Poulsen PL, Thomsen RW, Sattar N, Sørensen HT, Maeng M

doi: 10.1186/s12933-026-03085-4

Heart, Artery and Coronary Diseases

Association between SSRI use and cardiovascular outcomes in patients with coronary artery disease and generalized anxiety disorder: A real-world cohort study

Atherosclerosis

Wu JY, Chang HY, Kao CL, Hung KC, Yu T, Lin YM

doi: 10.1016/j.atherosclerosis.2025.120390

Cardiovascular Risk and Diseases

Low serum 1,5-anhydroglucitol is associated with increased risk of all-cause and cardiovascular mortality in type 2 diabetes: A real-world cohort study

Diabetes Obes Metab

Ni J, Chen L, Su H, Cai J, Wang C, Lu W, Wang Y, Lu J, Xia T, Zhou J

doi: 10.1111/dom.70214

Cardiac Arrest or Death

Effects of withdrawal of life-sustaining therapy on long-term neurological outcome after cardiac arrest - a multicentre matched cohort study

Resuscitation

Lagebrant A, Lee BK, Youn CS, Sandroni C, Bělohlávek J, Cariou A, Carrai R, Dankiewicz J, Friberg H, Grejs AM, Grippo A, Hassager C, Horn J, Haenggi M, Jakobsen JC, Keeble TR, Kirkegaard H, Kjaergaard J, Kuiper MA, Lee DH, Levin H, Lilja G, Lundin A, Nielsen N, Oddo M, Oh SH, Park KN, Pellis T, Robba C, Rylander C, Ryu SJ, Saxena M, Scarpino M, Schrag C, Stammet P, Storm C, Taccone FS, Thomas M, Ullén S, Westhall E, Wise MP, Young P, Cronberg T, Moseby-Knappe M

doi: 10.1016/j.resuscitation.2025.110747

Hypertension

Real-World Experience with Selexipag in Patients with Pulmonary Arterial Hypertension: Treatment Patterns and Outcomes across Baseline Risk Strata (SPHERE and EXPOSURE Studies)

Drugs Real World Outcomes

Escribano Subias P, Chakinala MM, Chin KM, Didden EM, Doad G, Farber HW, Gaine S, Hemnes AR, Highland KB, Lange TJ, McLaughlin V, Muller A, Rahman M, Remeňová T, Söderberg S, Venkatesh A, Kim NH

doi: 10.1007/s40801-025-00536-4

Atrial FibrillationFurther Publications

Impact of GLP-1 Receptor Agonist Therapy on Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients: A Real-World Data Analysis

Circ Arrhythm Electrophysiol

Venier S, Defaye P, Lochon L, Benali R, Bisson A, Carabelli A, Diouf Y, Jacon P, Fauchier L

doi: 10.1161/CIRCEP.125.014101

Heart Failure

Prognosis After >50% Decline in eGFR in Heart Failure Patients: A Nationwide Real-World Study

JACC Heart Fail

Anjum DZ, Elmegaard M, Garred CH, Nouhravesh N, Fosbol E, Jhund PS, McMurray JJV, Petrie MC, Køber L, Schou M

doi: 10.1016/j.jchf.2025.02.027

COMMENTED

Cardiovascular Risk and Diseases

Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

Lancet Diabetes Endocrinol

Patsoukaki V, Lind L, Lampa E, Radhi S, Eeg-Olofsson K, Eliasson B, Eriksson JW

doi: 10.1016/S2213-8587(25)00165-2

Heart Failure

Prognostic Impact of Cardiovascular-Kidney-Metabolic Overlap Among Patients With Acute Heart Failure: Insights From a Real-World Multinational Cohort

J Am Heart Assoc

Marchetti M, Antiochos P, Pitta-Gros B, Abdurashidova T, Soborun N, Monney P, Yerly P, Tzimas G, Skalidis I, Vollenweider P, Gencer B, Fakhouri F, Vaduganathan M, Hullin R, Lu H

doi: 10.1161/JAHA.125.045294

Related content